Ghost Tree Capital, LLC Acadia Pharmaceuticals Inc Transaction History

Ghost Tree Capital, LLC

$245 Million
Q2 2024

A detailed history of Ghost Tree Capital, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 225,000 shares of ACAD stock, worth $3.33 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

225,000

Previous 225,000 -0.0%

Holding current value

$3.33 Million

Previous $4.16 Million 12.12%

% of portfolio

1.49%

Previous 1.34%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $3.11 Million - $5.4 Million	175,000 Added 350.0%	225,000 $4.16 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $623,400 - $953,100	-30,000 Reduced 37.5%	50,000 $1.57 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $1.67 Million - $2.68 Million	80,000 New	80,000 $1.67 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $6.01 Million - $9.41 Million	-165,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $6.48 Million - $8.7 Million	165,000 New	165,000 $8 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $16.7 Million - $33 Million	-750,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $3.5 Million - $4.22 Million	-150,000 Reduced 16.67%	750,000 $20 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $12.5 Million - $21.2 Million	775,000 Added 620.0%	900,000 $24.2 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $5.37 Million - $8.6 Million	-375,000 Reduced 75.0%	125,000 $2.02 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $456,050 - $763,350	-35,000 Reduced 6.54%	500,000 $10.4 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $2.03 Million - $3.02 Million	135,000 Added 33.75%	535,000 $8.17 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $8.99 Million - $12.9 Million	400,000 New	400,000 $8.99 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Acadia Pharmaceuticals Inc Transaction History